December 14, 2016
11am EST to 12pm EST

Sponsored by
Diaceutics Group logo



Webinar Description:

Who, in pharma, is ready to capitalize on the PM business model? This is the question we will explore and answer in this 60-minute webinar focusing on pharma’s commercial readiness to operate in the personalized medicine marketplace. Diaceutics’ experienced data analysts will guide you through the pharma competitive landscape, new entrants to the space and highlight what companies have moved up or down in this year’s rankings.

Learning Objectives:

  • Overview and assessment of the PM Industry
  • Benchmarking of the top 14 companies succeeding in the space and impact on their business
  • Best practice examples and the preferred organizational style of a successful PM business model
  • Impact of PM readiness on revenues and financial risks for the sector
  • Predictions and insights on what to expect in 2017


Ewelina Golebiewska, Ph.D.

Data Analyst and Consultant

Diaceutics AIS

Ewelina has a PhD from the University of Bristol and postdoctoral experience in the UK and Japan. In her role as Data Analyst and Consultant, Ewelina is responsible for expansion of the Diaceutics AIS Analytics capabilities, as well as development and management of data-driven products offering.

Steve Vitale, MBA

Managing Director

Diaceutics AIS

With over 20 years' experience, Steve has held several senior roles at GlaxoSmithKline including Innovation Director, US Vaccines, where he spearheaded the creation of the innovation function and drove development of novel services and solutions to remove barriers customers face throughout the immunization process; Marketing Director, Hib / Meningitis Vaccines, where he launched Hiberix® in the US market and led all pre-commercial and marketing activities supporting the MenHibrix® launch. Steve also served as Director, Global Commercial Strategy, Cardiovascular / Metabolic where he drove commercial assessments, evolution of product life cycle and market development opportunities for the diabetes franchise. Steve has recently joined Diaceutics from TGaS Advisors, LLC where he was Head of the TGaS Marketing Benchmark Solution. He has an M.BA. from The Tepper School of Business at Carnegie Mellon University in Pittsburgh, PA and BA in Political Science from Amherst College in Amherst, MA.

Complimentary Report

Diaceutics will provide a complimentary copy of their updated PM Readiness Report to only those attendees joining the webinar on December 14th